The triumph of the Oxford-AstraZeneca vaccine
Despite setbacks, the jab has probably saved more lives than any other
IN A SOLEMN pre-recorded address, Boris Johnson warned Britons that a “tidal wave” of Omicron was on its way, and that the best chance of escape lay in booster vaccines. All adults, the prime minister announced on December 12th, would be offered one by the end of 2021. Yet their choice is to be more limited than in the last vaccination push, with Moderna and Pfizer leading the way. Nearly a year after it was first approved, Britain’s flagship Oxford-AstraZeneca jab will be rarely used.
This article appeared in the Britain section of the print edition under the headline “A dose for the world”
From the December 18th 2021 edition
Discover stories from this section and more in the list of contents
Explore the editionDiscover more
The slow death of a Labour buzzword
And what that says about Britain’s place in the world
Britain’s Supreme Court considers what a woman is
At last. Britons had been wondering what those 34m people who are not men might be
Can potholes fuel populism?
A new paper looks at one explanation for the rise of Reform UK
Are British voters as clueless as Labour’s intelligentsia thinks?
How the idea of false consciousness conquered the governing party